| A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population MJ Herrero, J Blanch, JM Peri, J De Pablo, L Pintor, A Bulbena General hospital psychiatry 25 (4), 277-283, 2003 | 988 | 2003 |
| The 5‐HT2A receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients B Arias, C Gastó, R Catalán, B Gutiérrez, L Pintor, L Fañanás American journal of medical genetics 105 (8), 801-804, 2001 | 171 | 2001 |
| Relapse of major depression after complete and partial remission during a 2-year follow-up L Pintor, C Gastó, V Navarro, X Torres, L Fañanas Journal of Affective Disorders 73 (3), 237-244, 2003 | 155 | 2003 |
| Variability in the serotonin transporter gene and increased risk for major depression with melancholia B Gutiérrez, L Pintor, C Gastó, A Rosa, J Bertranpetit, E Vieta, L Fañanás Human genetics 103, 319-322, 1998 | 148 | 1998 |
| Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study V Navarro, C Gastó, X Torres, G Masana, R Penadés, J Guarch, ... The American Journal of Geriatric Psychiatry 16 (6), 498-505, 2008 | 112 | 2008 |
| Variability in the 5-HT2A receptor gene is associated with seasonal pattern in major depression B Arias, B Gutierrez, L Pintor, C Gasto, L Fananas Molecular psychiatry 6 (2), 239-242, 2001 | 105 | 2001 |
| Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up? L Pintor, X Torres, V Navarro, S Matrai, C Gastó Journal of affective disorders 82 (2), 291-296, 2004 | 103 | 2004 |
| Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders B Gutiérrez, B Arias, C Gastó, R Catalán, S Papiol, L Pintor, L Fañanás Psychiatric genetics 14 (4), 203-208, 2004 | 99 | 2004 |
| Inflammatory bowel disease and eating disorders: a systematized review of comorbidity L Ilzarbe, M Fàbrega, R Quintero, A Bastidas, L Pintor, J García-Campayo, ... Journal of psychosomatic research 102, 47-53, 2017 | 85 | 2017 |
| Citalopram versus nortriptyline in late‐life depression: a 12‐week randomized single‐blind study V Navarro, C Gasto, X Torres, T Marcos, L Pintor Acta Psychiatrica Scandinavica 103 (6), 435-440, 2001 | 80 | 2001 |
| Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies M Carreño, CG Bien, AA Asadi-Pooya, M Sperling, P Marusic, M Elisak, ... Epilepsy research 129, 101-105, 2017 | 74 | 2017 |
| COVID-19 inpatients with psychiatric disorders: real-world clinical recommendations from an expert team in consultation-liaison psychiatry G Anmella, N Arbelo, G Fico, A Murru, CD Llach, S Madero, ... Journal of Affective Disorders 274, 1062-1067, 2020 | 73 | 2020 |
| Neuropsychological tests with lateralizing value in patients with temporal lobe epilepsy: Reconsidering material-specific theory T Raspall, M Doñate, T Boget, M Carreño, A Donaire, R Agudo, ... Seizure 14 (8), 569-576, 2005 | 73 | 2005 |
| Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT1A receptor gene as putative risk factors in major depression B Arias, MJ Arranz, C Gasto, R Catalan, L Pintor, B Gutierrez, RW Kerwin, ... Molecular Psychiatry 7 (9), 930-932, 2002 | 72 | 2002 |
| Changes in dreaming induced by CPAP in severe obstructive sleep apnea syndrome patients EVA Carrasco, J Santamaria, A Iranzo, L Pintor, JDE PABLO, A Solanas, ... Journal of sleep research 15 (4), 430-436, 2006 | 69 | 2006 |
| Prevalence of interictal psychiatric disorders in patients with refractory temporal and extratemporal lobe epilepsy in Spain. A comparative study V Sanchez‐Gistau, L Pintor, G Sugranyes, E Baillés, M Carreño, ... Epilepsia 51 (7), 1309-1313, 2010 | 66 | 2010 |
| Psychiatric disorders in temporal lobe epilepsy patients over the first year after surgical treatment L Pintor, E Bailles, E Fernández-Egea, V Sánchez-Gistau, X Torres, ... Seizure 16 (3), 218-225, 2007 | 59 | 2007 |
| Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial L Pintor, F Valldeoriola, E Baillés, MJ Martí, A Muñiz, E Tolosa Clinical neuropharmacology 35 (2), 61-66, 2012 | 58 | 2012 |
| Representation and outcomes of individuals with schizophrenia seen in everyday practice who are ineligible for randomized clinical trials H Taipale, J Schneider-Thoma, J Pinzón-Espinosa, J Radua, O Efthimiou, ... JAMA psychiatry 79 (3), 210-218, 2022 | 57 | 2022 |
| PET/MRI and PET/MRI/SISCOM coregistration in the presurgical evaluation of refractory focal epilepsy S Fernández, A Donaire, E Serès, X Setoain, N Bargalló, C Falcón, ... Epilepsy Research 111, 1-9, 2015 | 57 | 2015 |
